These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2604747)

  • 1. Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A.
    Coley HM; Twentyman PR; Workman P
    Biochem Pharmacol; 1989 Dec; 38(24):4467-75. PubMed ID: 2604747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A.
    Coley HM; Twentyman PR; Workman P
    Cancer Chemother Pharmacol; 1989; 24(5):284-90. PubMed ID: 2547527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efflux of anthracyclines in multidrug-resistant cell lines.
    Coley HM; Twentyman PR; Workman P
    Biochem Pharmacol; 1993 Oct; 46(8):1317-26. PubMed ID: 7902089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistance.
    Coley HM; Twentyman PR; Workman P
    Anticancer Drug Des; 1992 Dec; 7(6):471-81. PubMed ID: 1337431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical synthesis and biological properties of novel fluorescent antifolates in Pgp- and MRP-overexpressing tumour cell lines.
    Robson C; Wright KA; Twentyman PR; Lambert PA; Griffin RJ
    Biochem Pharmacol; 1998 Oct; 56(7):807-16. PubMed ID: 9774142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines.
    Coley HM; Amos WB; Twentyman PR; Workman P
    Br J Cancer; 1993 Jun; 67(6):1316-23. PubMed ID: 8099807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
    Watanabe M; Komeshima N; Naito M; Isoe T; Otake N; Tsuruo T
    Cancer Res; 1991 Jan; 51(1):157-61. PubMed ID: 1988080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells.
    Ishida Y; Shimada Y; Shimoyama M
    Jpn J Cancer Res; 1990 Aug; 81(8):834-41. PubMed ID: 2118896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil.
    Shrivastava P; Hanibuchi M; Yano S; Parajuli P; Tsuruo T; Sone S
    Cancer Chemother Pharmacol; 1998; 42(6):483-90. PubMed ID: 9788575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
    Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
    Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines.
    Dong J; Naito M; Tatsuta T; Seimiya H; Johdo O; Tsuruo T
    Oncol Res; 1995; 7(5):245-52. PubMed ID: 8534930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
    Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems.
    Cleary I; Doherty G; Moran E; Clynes M
    Biochem Pharmacol; 1997 May; 53(10):1493-502. PubMed ID: 9260877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression.
    Coley HM; Workman P; Twentyman PR
    Br J Cancer; 1991 Mar; 63(3):351-7. PubMed ID: 1672252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular levels of two cyclosporin derivatives valspodar (PSC 833) and cyclosporin a closely associated with multidrug resistance-modulating activity in sublines of human colorectal adenocarcinoma HCT-15.
    Uchiyama-Kokubu N; Watanabe T; Cohen D
    Jpn J Cancer Res; 2001 Oct; 92(10):1116-26. PubMed ID: 11676863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of a mouse tumour cell line with in vitro derived resistance to verapamil.
    Twentyman PR; Wright KA; Fox NE
    Br J Cancer; 1990 Feb; 61(2):279-84. PubMed ID: 1968761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.
    Twentyman PR; Rhodes T; Rayner S
    Eur J Cancer; 1994; 30A(9):1360-9. PubMed ID: 7999426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative.
    Dale IL; Tuffley W; Callaghan R; Holmes JA; Martin K; Luscombe M; Mistry P; Ryder H; Stewart AJ; Charlton P; Twentyman PR; Bevan P
    Br J Cancer; 1998 Oct; 78(7):885-92. PubMed ID: 9764579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activity of deoxyspergualin in multidrug-resistant cells.
    Holmes JA; Twentyman PR
    Cancer Chemother Pharmacol; 1995; 36(6):499-505. PubMed ID: 7554042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane potential differences between adriamycin-sensitive and -resistant cells as measured by flow cytometry.
    Hasmann M; Valet GK; Tapiero H; Trevorrow K; Lampidis T
    Biochem Pharmacol; 1989 Jan; 38(2):305-12. PubMed ID: 2914014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.